Exclusive: China's Shein files for U.S. IPO -sources
a year later amid Beijing's crackdown on Chinese technology giants over antitrust and data security rules.
Shein has confidentially submitted its IPO registration with the U.S. Securities and Exchange Commission , the sources said. The stock market debut could come before the end of 2023, the sources added.A spokesperson for Shein said by email that the company "denies these rumors." The spokesperson did not immediately respond to a request for further details. The SEC declined to comment.
Shein has been eyeing a U.S. IPO for at least three years, but was deterred by headwinds that included U.S. scrutiny of Chinese accounting practices and bouts of market volatility fueled by the COVID-19 pandemic and Russia's war in Ukraine. The company's founder Chris Xu moved the company's headquarters to Singapore from Nanjing, capital of China's eastern Jiangsu province, more than a year ago, a move that helps Shein circumvent China's tough new rules on overseas listings.Our Standards:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
China fast-fashion retailer Shein files for U.S. IPO: reportShein, a large online fast-fashion retailer based in China, has filed for an initial public offering, Reuters reported on Thursday, citing people familiar...
Baca lebih lajut »
WSJ News Exclusive | U.S. Considers New Curbs on AI Chip Exports to ChinaThe Biden administration is considering new restrictions on exports of artificial intelligence chips to China, as concerns rise over the power of the technology in the hands of U.S. rivals
Baca lebih lajut »
Shein, the fast-fashion giant, hits roadblocksKnown for its low prices and on-trend manufacturing process, Shein faces backlash after an influencer trip to its China headquarters and D.C. lawmakers are also asking questions about their factories.
Baca lebih lajut »
Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPOInsilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin’s B Capital, among others.
Baca lebih lajut »
FIFTY FIFTY Files To Suspend Exclusive Contracts With ATTRAKTFIFTYFIFTY Files To Suspend Exclusive Contracts With ATTRAKT
Baca lebih lajut »